Cardiovascular Systems, Inc.
CSII
CSII was delisted on the 27th of April, 2023.
1 hedge funds and large institutions have $20 invested in Cardiovascular Systems, Inc. in 2023 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less capital invested
Capital invested by funds: $1.37M → $20 (-$1.37M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
-$1.37M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HNB
1
Huntington National Bank
Columbus,
Ohio
| $20 | – | – | – |
|
|
2
UBS AM
Chicago,
Illinois
| – | -$1.37M | -69,146 | Closed |
|
CSII Hedge Fund Activity: Q3 2023 in Review
1 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q3 2023, worth a combined $20 — down 100% from $1.37M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CSII and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS AM, exiting entirely with an estimated $1.37M sold.
- 1 institutional investor held Cardiovascular Systems, Inc. (CSII) as of Q3 2023, down from 2 in Q2 2023.
- Funds reported $20 of Cardiovascular Systems, Inc. stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new Cardiovascular Systems, Inc. positions in Q3 2023 and 1 closed out, a net change of -1 holder.
- The largest Cardiovascular Systems, Inc. seller in Q3 2023 was UBS AM, an estimated $1.37M sold.
Based on aggregated 13F filings for Q3 2023.